T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
This study is currently recruiting participants.
Verified April 2010 by National Cancer Institute (NCI)
Sponsor:
University Hospital Birmingham
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00986557
First received: September 29, 2009
Last updated: September 20, 2011
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |